Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN249633 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interferon Regulatory Factor 5 (IRF5) (C-Term), (all Isoforms) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Goat
- Epitope
- C-Term, all Isoforms
- Vial size
- 0.1 mg
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality.
MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection.
IRF5 is required for late-phase TNF secretion by human dendritic cells.
IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway.
Methamphetamine enhances Hepatitis C virus replication in human hepatocytes.
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.
Li D, De S, Li D, Song S, Matta B, Barnes BJ
Scientific reports 2016 Aug 2;6:31002
Scientific reports 2016 Aug 2;6:31002
MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection.
Hanke ML, Angle A, Kielian T
PloS one 2012;7(8):e42476
PloS one 2012;7(8):e42476
IRF5 is required for late-phase TNF secretion by human dendritic cells.
Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA
Blood 2010 Jun 3;115(22):4421-30
Blood 2010 Jun 3;115(22):4421-30
IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway.
Hu G, Barnes BJ
The Journal of biological chemistry 2009 Jan 30;284(5):2767-77
The Journal of biological chemistry 2009 Jan 30;284(5):2767-77
Methamphetamine enhances Hepatitis C virus replication in human hepatocytes.
Ye L, Peng JS, Wang X, Wang YJ, Luo GX, Ho WZ
Journal of viral hepatitis 2008 Apr;15(4):261-70
Journal of viral hepatitis 2008 Apr;15(4):261-70
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, Plenge RM, Koeuth T, Ortmann WA, Hom G, Bauer JW, Gillett C, Burtt N, Cunninghame Graham DS, Onofrio R, Petri M, Gunnarsson I, Svenungsson E, Rönnblom L, Nordmark G, Gregersen PK, Moser K, Gaffney PM, Criswell LA, Vyse TJ, Syvänen AC, Bohjanen PR, Daly MJ, Behrens TW, Altshuler D
Proceedings of the National Academy of Sciences of the United States of America 2007 Apr 17;104(16):6758-63
Proceedings of the National Academy of Sciences of the United States of America 2007 Apr 17;104(16):6758-63
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
Ning S, Huye LE, Pagano JS
Journal of virology 2005 Sep;79(18):11671-6
Journal of virology 2005 Sep;79(18):11671-6
Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.
Barnes BJ, Moore PA, Pitha PM
The Journal of biological chemistry 2001 Jun 29;276(26):23382-90
The Journal of biological chemistry 2001 Jun 29;276(26):23382-90
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
